Remarkable reduction of LDL-c with antibody against angiopoietin-like protein 3 in HoFH - PACE-CME

Remarkable reduction of LDLc with antibody against angiopoietinlike protein in HoFH

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

One step closer to controlling LDL-c levels in HoFH with PCSK9i
One step closer to controlling LDL-c levels in HoFH with PCSK9i
ACC 2020
One step closer to controlling LDL-c levels in HoFH with PCSK9i
- Dirk Blom, PhD
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
ACC 2020
Reduced bleeding with P2Y12i monotherapy after 3 months DAPT after complex PCI
- Prof. George Dangas, MD, PhD
Mechanistic underpinning of CV benefit observed with icosapent ethyl
Mechanistic underpinning of CV benefit observed with icosapent ethyl
ACC 2020
Mechanistic underpinning of CV benefit observed with icosapent ethyl
- Deepak Bhatt, MD
Stopping with aspirin after 3 months DAPT is safe in a wide range of patients
Stopping with aspirin after 3 months DAPT is safe in a wide range of patients
ACC 2020
Stopping with aspirin after 3 months DAPT is safe in a wide range of patients
- Prof. Freek Verheugt, MD